Conjunctival granuloma, bilateral
ICD-10 H11.223 is a billable code used to indicate a diagnosis of conjunctival granuloma, bilateral.
Conjunctival granuloma, bilateral, is characterized by the formation of localized inflammatory lesions on the conjunctiva, the thin membrane covering the white part of the eye and the inner eyelids. Clinically, patients may present with symptoms such as redness, swelling, irritation, and discomfort in both eyes. The condition can arise from various etiologies, including chronic inflammation, foreign body reactions, or infections. The conjunctiva is composed of epithelial and connective tissue, and granulomas typically develop as a response to persistent irritants or infections. Disease progression can lead to complications such as scarring or vision impairment if left untreated. Diagnostic considerations include a thorough patient history, physical examination, and possibly biopsy to differentiate conjunctival granuloma from other conjunctival lesions, such as papillomas or neoplasms. Management often involves addressing the underlying cause, which may include corticosteroids or surgical intervention for larger granulomas.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H11.223 specifically covers bilateral conjunctival granulomas, which may arise from chronic irritation, infections, or foreign body reactions. It is essential to differentiate this condition from other conjunctival disorders such as conjunctivitis or neoplasms.
H11.223 should be used when bilateral conjunctival granulomas are diagnosed, particularly when symptoms and clinical findings are present in both eyes. It is crucial to differentiate it from unilateral conditions or other conjunctival lesions.
Documentation should include a detailed patient history, clinical examination findings, and any diagnostic tests performed. A clear description of the bilateral nature of the granulomas and the underlying causes should be documented to support the use of H11.223.
